Literature DB >> 30349608

Improving Quality of Life in Patients with Pituitary Tumours.

Iris Crespo1, Alicia Santos1, Eugenia Resmini1, Elena Valassi1, Maria Antonia Martínez-Momblán1,2, Susan M Webb1.   

Abstract

Evaluation of health-related quality of life (QoL) in people with pituitary tumours has received much attention over the last 10-15 years. Most of them show impaired QoL, but little is known about how to prevent impairment or how to improve QoL. Our aim is to review what is known about QoL in pituitary tumours patients and to highlight the areas worth improving, for the patient's well being. The article has four sections: acromegaly, Cushing's syndrome, prolactinomas and non-functioning adenomas. Control of comorbidities is usually an important factor to prevent QoL impairment; however, each disease has specific characteristics that should be properly addressed in order to obtain full patient recovery after successful therapy.

Entities:  

Keywords:  Cushing’s syndrome; Quality of life; acromegaly; non-functioning adenomas; pituitary tumours; prolactinomas

Year:  2013        PMID: 30349608      PMCID: PMC6193521          DOI: 10.17925/EE.2013.09.01.32

Source DB:  PubMed          Journal:  Eur Endocrinol        ISSN: 1758-3772


  82 in total

1.  Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon.

Authors:  N J Gittoes; M C Sheppard; A P Johnson; P M Stewart
Journal:  QJM       Date:  1999-12

2.  Long-term results of total adrenalectomy for Cushing's disease.

Authors:  S K Nagesser; A P van Seters; J Kievit; J Hermans; H M Krans; C J van de Velde
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood.

Authors:  Andrea F Attanasio; Elena P Shavrikova; Werner F Blum; Stephen M Shalet
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

5.  The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.

Authors:  Elena Valassi; Alicia Santos; Maria Yaneva; Miklós Tóth; Christian J Strasburger; Philippe Chanson; John A H Wass; Olivier Chabre; Marija Pfeifer; Richard A Feelders; Stylianos Tsagarakis; Peter J Trainer; Holger Franz; Kathrin Zopf; Sabina Zacharieva; Steven W J Lamberts; Antoine Tabarin; Susan M Webb
Journal:  Eur J Endocrinol       Date:  2011-06-29       Impact factor: 6.664

Review 6.  [Growth hormone therapy in adult patients: a review].

Authors:  Peter Herbert Kann
Journal:  Wien Klin Wochenschr       Date:  2011-05-18       Impact factor: 1.704

7.  Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.

Authors:  Maria P Matta; Elisabeth Couture; Laurent Cazals; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

8.  Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.

Authors:  Sarah K Thompson; Amanda V Hayman; William H Ludlam; Clifford W Deveney; D Lynn Loriaux; Brett C Sheppard
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease.

Authors:  Mary T Hawn; David Cook; Clifford Deveney; Brett C Sheppard
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

10.  Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.

Authors:  Agatha A van der Klaauw; Nienke R Biermasz; Hendrieke C Hoftijzer; Alberto M Pereira; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

View more
  2 in total

1.  A Prospective Evaluation of Quality of Life in Patients Undergoing Extended Endoscopic Endonasal Surgery for Benign Pituitary Gland Lesion.

Authors:  Narin Nard Carmel Neiderman; Anat Wengier; Omri Dominsky; Barak Ringel; Anton Warshavsky; Gilad Horowitz; Tomer Ziv Baran; Zvi Ram; Rachel Grossman; Dan Marian Fliss; Abergel Avraham
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

2.  Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study).

Authors:  Muhammad Fahad Arshad; Oluwafunto Ogunleye; Richard Ross; Miguel Debono
Journal:  Pituitary       Date:  2021-05-12       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.